Optimal Initial Dose of Levothyroxine for Treatment of Congenital Hypothyroidism

陈肖肖,施玉华,曹丽佩,周雪莲,杨茹莱,毛华庆,赵正言

DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2010.04.004

2010-01-01

Abstract:Objective The purpose of this study was to investigate the optimal initial dose of levothyroxine(L-T_4)for treatment of congenital hypothyroidism(CH).Methods One hundred and twenty-seven CH infants were assigned to A(n=36),B(n=51),and C(n=40)groups.Different initial doses were given to the patients,10 μg·kg~(-1)·d~(-1) for A group,8 μg·kg~(-1)·d~(-1) for B group and 6 μg·kg~(-1)·d~(-1) for C group.Blood TSH,L and FT_4 Ievels were determined at 2 weeks,4-6 weeks and 8-12 weeks after medication.L-T_4 dose was adiusted individually according to the blood hormone levels.Thyroid hormone levels were rechecked every three months after 12 weeks of medication.All the patients were followed up for 2 years,with regular assessment of growth,development,and thyroid ultrasonography.Results After 2 weeks'medication,TSH levels in both A and B groups were reduced to reference range[(1.3±1.5)mU/L and(3.7±5.6)mU/L].No difference was found between the 2 groups(P=0.28).Eight patients(22.2%)in the A group had a reduced TSH level to less than0.5 mU/L.TSH level in the C group remained abnormal[(11.4±16.5)mU/L]and significant difierence was observed when compared with those in the B and C groups(P<0.01).10 patients in the C group had a TSH level more than 10 mU/L[(34.0±19.2)mU/L].T_4 and FT_4 levels in all the three groups increased markedly.9patients(25.0%)in the A group had T_4 level more than 250 nmol/L,and 11 patients(30.6%)showed hyperthyroxinemia with FT_4 level more than 45 pmol/L(1.5 folds of upper limit of the reference range).13patients in the A group showed clinical symptoms of hyperthyroidism such as diarrhea,irritability,sweating,cry,and so on.After 12 weeks medication,no significant difference was found in blood TSH,T_4,and FT_4 levels among the 3 groups.Also no difference was observed in adjusted L-T_4 dosages among the 3 groups.After 2-year follow-up,clinical examinations including height,weight,bone age,and mental development were all normal for the patients.No differences were found among the 3 groups(all P>0.05).Conclusions Optimal initial dosage of L-T_4 for CH treatment in our country is(8.0±0.5)μg·kg~(-1)·d~(-1) which is proved to be safe and effective.L-T_4dosage should be individualized.To maintain the thyroid function in the age-matched normal reference will lead to normal growth and development.